PL367796A1 - Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-ylo octowego - Google Patents

Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-ylo octowego

Info

Publication number
PL367796A1
PL367796A1 PL02367796A PL36779602A PL367796A1 PL 367796 A1 PL367796 A1 PL 367796A1 PL 02367796 A PL02367796 A PL 02367796A PL 36779602 A PL36779602 A PL 36779602A PL 367796 A1 PL367796 A1 PL 367796A1
Authority
PL
Poland
Prior art keywords
dimethyl
dihydro
chlorophenyl
phenyl
pyrrolizin
Prior art date
Application number
PL02367796A
Other languages
English (en)
Inventor
Gerd Dannhardt
Thomas Kammermeier
Philipp Merckle
Hans-Günter Striegel
Stefan Laufer
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of PL367796A1 publication Critical patent/PL367796A1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL02367796A 2001-08-23 2002-08-21 Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-ylo octowego PL367796A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10141285A DE10141285A1 (de) 2001-08-23 2001-08-23 Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
PCT/EP2002/009356 WO2003018583A1 (de) 2001-08-23 2002-08-21 Verfahren zur herstellung von 6-(4-chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl-essigsäure

Publications (1)

Publication Number Publication Date
PL367796A1 true PL367796A1 (pl) 2005-03-07

Family

ID=7696330

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02367796A PL367796A1 (pl) 2001-08-23 2002-08-21 Sposób wytwarzania kwasu 6-(4-chlorofenylo)-2,2-dimetylo-7-fenylo-2,3-dihydro-1H-pirolizyn-5-ylo octowego

Country Status (31)

Country Link
US (1) US7078535B2 (pl)
EP (1) EP1419160B1 (pl)
JP (1) JP4195379B2 (pl)
KR (1) KR100687472B1 (pl)
CN (1) CN1266152C (pl)
AR (1) AR035117A1 (pl)
AT (1) ATE417047T1 (pl)
AU (1) AU2002331168C1 (pl)
BR (1) BR0212009A (pl)
CA (1) CA2458339C (pl)
CO (1) CO5560556A2 (pl)
CU (1) CU23345A3 (pl)
CY (1) CY1109089T1 (pl)
DE (2) DE10141285A1 (pl)
DK (1) DK1419160T3 (pl)
EA (1) EA006436B1 (pl)
ES (1) ES2319268T3 (pl)
GE (1) GEP20063918B (pl)
HR (1) HRP20040263B1 (pl)
HU (1) HU228125B1 (pl)
IL (2) IL160047A0 (pl)
MX (1) MXPA04001664A (pl)
NO (1) NO328299B1 (pl)
NZ (1) NZ531113A (pl)
PL (1) PL367796A1 (pl)
PT (1) PT1419160E (pl)
RS (1) RS51877B (pl)
TW (1) TWI274755B (pl)
UA (1) UA75702C2 (pl)
WO (1) WO2003018583A1 (pl)
ZA (1) ZA200402209B (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005012971A1 (de) * 2005-03-21 2006-09-28 Merckle Gmbh Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
WO2007108006A1 (en) * 2006-03-23 2007-09-27 Unichem Laboratories Limited Process for the preparation of 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2, 3-dihydro-1h-pyrrolizin-5-yl acetic acid and its intermediates
CZ2007752A3 (cs) * 2007-10-30 2009-05-13 Zentiva, A. S. Nový zpusob výroby 2-(6-(4-chlorfenyl)-2,2-dimethyl-7-fenyl-2,3-dihydro-1H-pyrrolizin-5-yl)octové kyseliny (licofelonu)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0172371A1 (de) 1984-07-27 1986-02-26 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von Dehydroxypantolacton
DE3915450A1 (de) 1989-05-11 1990-11-15 Gerd Prof Dr Dannhardt Substituierte pyrrolverbindungen und deren anwendung in der pharmazie
DE4419246A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
DE4419315A1 (de) 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
EE05125B1 (et) * 2000-01-28 2009-02-16 Merckle Gmbh 6-(4-klorofenl)-2,2-dimetl-7-fenl-2,3-dihdro-1H-prrolisiin-5-l„„dikhappe valmistamismeetod

Also Published As

Publication number Publication date
JP2005501871A (ja) 2005-01-20
EA200400344A1 (ru) 2004-08-26
MXPA04001664A (es) 2004-05-31
IL160047A (en) 2010-11-30
BR0212009A (pt) 2004-09-28
AU2002331168B2 (en) 2007-11-15
DE50213105D1 (de) 2009-01-22
DK1419160T3 (da) 2009-04-14
HUP0401440A2 (hu) 2004-11-29
HRP20040263B1 (hr) 2012-07-31
JP4195379B2 (ja) 2008-12-10
HUP0401440A3 (en) 2008-03-28
NO20041178L (no) 2004-04-22
RS51877B (sr) 2012-02-29
HRP20040263A2 (en) 2004-08-31
GEP20063918B (en) 2006-09-11
CN1266152C (zh) 2006-07-26
US7078535B2 (en) 2006-07-18
WO2003018583A1 (de) 2003-03-06
AU2002331168C1 (en) 2008-06-05
CY1109089T1 (el) 2014-07-02
CA2458339A1 (en) 2003-03-06
CU23345A3 (es) 2009-02-20
KR20040029006A (ko) 2004-04-03
EA006436B1 (ru) 2005-12-29
ATE417047T1 (de) 2008-12-15
PT1419160E (pt) 2009-03-17
HK1060879A1 (en) 2004-08-27
IL160047A0 (en) 2004-06-20
ZA200402209B (en) 2005-05-11
KR100687472B1 (ko) 2007-02-27
TWI274755B (en) 2007-03-01
CN1545516A (zh) 2004-11-10
CA2458339C (en) 2009-07-21
AR035117A1 (es) 2004-04-14
UA75702C2 (en) 2006-05-15
EP1419160A1 (de) 2004-05-19
EP1419160B1 (de) 2008-12-10
NO328299B1 (no) 2010-01-25
US20040236117A1 (en) 2004-11-25
NZ531113A (en) 2005-12-23
CO5560556A2 (es) 2005-09-30
RS14604A (sr) 2007-02-05
DE10141285A1 (de) 2003-03-27
HU228125B1 (en) 2012-12-28
ES2319268T3 (es) 2009-05-06

Similar Documents

Publication Publication Date Title
DE69624695D1 (de) VERFAHREN ZUR SPEZIFISCHEN KOPPLUNG EINER SCHUTZGRUPPE AN DAS 5'-ENDE EINES mRNA-FRAGMENTES UND DIE HERSTELLUNG VON mRNA UND VOLLSTÄNDIGER cDNA
MXPA03004187A (es) Produccion de acido 6-aminocaproico.
WO2004080958A3 (en) Process to tetrahydrotriazolopyrazines and intermediates
DE69901758D1 (de) Verfahren zur herstellung von tetrahydrofuran, gammabutyrolacton un butandiol
DE502004000547D1 (de) Verfahren zur fermentativen Herstellung von L-Methionin
WO2002026705A3 (en) Highly enantiomerically pure lactam-substituted propanoic acid derivatives and their preparation
ATE277915T1 (de) Verfahren sowie neue zwischenprodukte zur herstellung von isoxazolin-3-yl-acylbenzolen
IL160047A (en) Method for the production of 6-(4- chlorophenyl)- 2,2- dimethyl- 7- phenyl- 2,3- dihydro-1h -pyrrolizin- 5-ylacetic acid
EP1038969A3 (de) Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung coryneformer Bakterien
DE60123334D1 (de) Methode für die Produktion von Nukleotiden durch Fermentierung
DE19881722D2 (de) Verfahren zum Herstellen von Nickel-Titan-Hohlprofilen
CA2412049A1 (en) Process for the preparation of 5-aminosalicyclic acid
DE69404409D1 (de) Verfahren zur Herstellung von Ceramiden
EP1229031A4 (en) PROCESS FOR THE PREPARATION OF 3,4-METHYLENEDIOXYMANDELIC ACID
EP1686114A4 (en) METHOD FOR PRODUCING OPTICALLY ACTIVE 2-ALKYLCYSTINE, DERIVATIVES AND MANUFACTURING METHOD
AU1517601A (en) Method for production of benzofuranone oximes
WO2002072723A3 (en) Gelatin manufacturing process and product
PL338215A1 (en) Method of obtaining 3-cyano-2,4-dichlorogeno-5-fluorobenzoic acids
ATE389710T1 (de) L-glutamine produzierende mikroorganismen und verfahren zur herstellung von l-glutamine unter verwendung derselben
ATE233822T1 (de) Verfahren zur stereoselektiven herstellung von substituierten cyclohexylcyanhydrinen
WO2001007631A3 (de) Neue Glykosyltransferase, ihre Herstellung und Verwendung
ATE250581T1 (de) Verfahren zur herstellung von 3-cyanopyridin aus 2-methyl-1,5-pentandiamin
DE50203529D1 (de) Verfahren zur herstellung von desclarithromycin, sowie zwischenprodukte
WO2003106432A8 (de) Verfahren zur herstellung von 4,6-dichlor-5-fluorpyrimidin
ATE231159T1 (de) Neues verfahren zur herstellung von etoposid

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)